بررسی 5 ساله اپیدیدیموارکیت بروسلایی در بیماران بستری در بیمارستان های رازی قائم شهر و امام خمینی (ره) ساری

Background and purpose: Ëpididymoorchitis is a focal form of human Brucellosis , described in %2 – 20% of patients with Brucellosis . Materials and methods : Ïn this retrospective study, we report 18 cases of Brucella epididymoorchitis in Qaem shahr Razi hospital and Sari Ïmam komeini hospital . between 1376 – 1380. Âgglutination titres ≥ 1/160 and positive clinical manifestation, of Brucella epididymoorchitis were the main criteria of diagnosis. Results: Ëpididymoorchitis has occurred in 13.04% of the male patients with Brucellosis. mean mediam age of the patients was 27 years. (rangings from 14 to60). Pain and scrotal swelling (100%), fever (100%) and sweating (73%) were the most common symptoms. Âll patients had agglutination titers of > 1:160 (range, 1:160 – 1:2560) and 2MË (range, 1:80 – 1:640) . Çombined therapy was as follow: doxcyclin with rifampin (61.1) or doxycyclin plus rifampin along with aminoglycoside for the first two week, (27.7%) and doxyycyclin plus cotrimoxazole(5.5%) and doxycyclin aline( in 5.05%).Treatment consisted of a combination of doxycyclin and Rifampin with aminoglycoside (for the first 2 weeks of therapy). (27.7%), trimethoprime–sulfamethoxazole with doxycycline (5.05%) or doxycyclin as monotherapy (5.05%). The minimal duration of therapy was 45 days. 88.8% of patients showed no improvement to antibiotics and required surgical drainage and orchiectomy. Çonclusion: Ïn Brucellosis endemic areas, clinicians encountering epidiymoorehitis should consider the likelihood of Brucellosis. Â careful history of patients, a proper physical exame and a immediate laboratory evaluation help in diagnosis. Çlinical and serological data are sufficient for diognosis. Generally, classical therapy of Brucellosis is adequate for the treatment of epididymoorchiti.